to homepage ZF-pharma BV    ZF-screens BV is a young spin-out company based on several patents generated by its
   founders Dr. Guido van den Thillart and Prof Dr. Herman Spaink.


to homepage NewCatch BV    The mission of ZF-screens BV is to develop products for pharmaceutical applications.
   One of our leading products, ZF-implant®, will be used as a tool for sustainable fish
   reproduction and is expected to be on the market soon.

   The unique combination of expertise in both Fish Physiology and Molecular Cell Biology
   makes ZF-screens BV distinctive in this expanding market.

Pharmaceutical applications
ZF-pharma BV is a daughter company of ZF-screens that develops products for pharmaceutical applications and screening purposes based on zebrafish technologies.

ZF-screens has a revolutionary patented platform technology to produce human proteins at much lower costs in GM-zebrafish cells.

Aquaculture applications
Daughter company NewCatch BV is developing ZF-implant® as a leading product.

This could in the near future enable fish farmers to control fish reproduction in aquaculture production, guaranteeing a normal development of the broodstock and high quality juveniles.


Latest News
14-05-2010
ZF-screens BV in Trouw (in Dutch)

14-11-2009
ZF-screens BV stated as innovative in "Bionieuws" (in Dutch)

28-10-2009
ZF-screens BV in De Telegraaf (in Dutch)

27-10-2009
Minister Verburg visits eel research facility in Leiden (in Dutch)


Last update 28 May 2010